Literature DB >> 17538631

Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis.

R E Seymour1, M G Hasham, G A Cox, L D Shultz, H Hogenesch, D C Roopenian, J P Sundberg.   

Abstract

Homologues of the SHARPIN (SHANK-associated RH domain-interacting protein) gene have been identified in the human, rat and mouse genomes. SHARPIN and its homologues are expressed in many tissues. SHARPIN protein forms homodimers and associates with SHANK in the post-synaptic density of excitatory neurotransmitters in the brain. SHARPIN is hypothesized to have roles in the crosslinking of SHANK proteins and in enteric nervous system function. We demonstrate that two independently arising spontaneous mutations in the mouse Sharpin gene, cpdm and cpdm(Dem), cause a chronic proliferative dermatitis phenotype, which is characterized histologically by severe inflammation, eosinophilic dermatitis and defects in secondary lymphoid organ development. These are the first examples of disease-causing mutations in the Sharpin gene and demonstrate the importance of SHARPIN protein in normal immune development and control of inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17538631     DOI: 10.1038/sj.gene.6364403

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  112 in total

1.  Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.

Authors:  Lizhi He; Alistair Ingram; Adrian P Rybak; Damu Tang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Discovery Genetics - The History and Future of Spontaneous Mutation Research.

Authors:  Muriel T Davisson; David E Bergstrom; Laura G Reinholdt; Leah Rae Donahue
Journal:  Curr Protoc Mouse Biol       Date:  2012-06-01

3.  Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex.

Authors:  Yusuke Sato; Hiroaki Fujita; Azusa Yoshikawa; Masami Yamashita; Atsushi Yamagata; Stephen E Kaiser; Kazuhiro Iwai; Shuya Fukai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-02       Impact factor: 11.205

4.  SHARPINing integrin inhibition.

Authors:  Mark D Bass
Journal:  Nat Cell Biol       Date:  2011-11-02       Impact factor: 28.824

Review 5.  Systems-level analysis of innate immunity.

Authors:  Daniel E Zak; Vincent C Tam; Alan Aderem
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 6.  Regulation of tumour necrosis factor signalling: live or let die.

Authors:  Dirk Brenner; Heiko Blaser; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

7.  SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes.

Authors:  Yanhua Liang; John P Sundberg
Journal:  J Dermatol Sci       Date:  2011-05-07       Impact factor: 4.563

Review 8.  Ubiquitination in disease pathogenesis and treatment.

Authors:  Doris Popovic; Domagoj Vucic; Ivan Dikic
Journal:  Nat Med       Date:  2014-11-06       Impact factor: 53.440

9.  A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.

Authors:  Neil Warner; Aaron Burberry; Luigi Franchi; Yun-Gi Kim; Christine McDonald; Maureen A Sartor; Gabriel Núñez
Journal:  Sci Signal       Date:  2013-01-15       Impact factor: 8.192

10.  Population genomics of parallel adaptation in threespine stickleback using sequenced RAD tags.

Authors:  Paul A Hohenlohe; Susan Bassham; Paul D Etter; Nicholas Stiffler; Eric A Johnson; William A Cresko
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.